Press Releases

LSPedia Achieves SOC 2 Type II, Independently Verifying How It Protects Supply Chain Data

November 17, 2026
By
Read Latest Issue

FARMINGTON HILLS, MI | November 17, 2026 – LSPedia, a leading provider of SaaS solutions for pharmaceutical compliance, serialization and traceability, today announced that it has completed a SOC 2 Type II examination with an unqualified opinion. Pharmaceutical manufacturers, wholesale distributors and 3PLs, health systems and pharmacies trust LSPedia with the serialized data that keeps the drug supply chain safe, and their security teams can now review an independent auditor's report on how LSPedia protects it.

The timing matters. Wholesaler DSCSA enforcement has been in effect since August 2025. More of the drug supply chain now exchanges serialized data every day, and buyers are looking harder at the vendors that hold it.

Before a company gives a software partner access to its supply chain data, its security team asks a simple question: are this vendor's controls real, and do they actually work? A SOC 2 Type II report answers with evidence instead of promises. A licensed CPA firm tested LSPedia's security controls over a full twelve months, from September 1, 2025, through August 31, 2026, and found they operated effectively. The examination covered the Security criteria, including how LSPedia manages access, system changes, risk, monitoring and incident response.

The report completes a set of independent credentials that answer the three questions customers ask most often. ISO 9001 shows that LSPedia delivers what it promises, consistently. ISO/IEC 27001:2022 shows that LSPedia manages security risk as a system. SOC 2 Type II shows that those security controls actually operated over time.

"Our customers are responsible for the safety of every product they move, and they need partners who take that responsibility as seriously as they do," said Riya Cao, Founder and CEO of LSPedia. "Their security teams shouldn't have to take our word for it. Now they don't have to."

"For the pharmaceutical industry companies we serve, DSCSA transaction records are what regulators and trading partners rely on, so any vendor holding them has to protect both their confidentiality and their integrity," said Tony Phoenix, Chief Information Security Officer at LSPedia. "Our SOC 2 Type II report and ISO 27001 certification give security teams independent evidence that our controls work. And when they have follow-up questions, our security team answers them directly."

‍

What this means for LSPedia customers

  • Evidence, not promises: An independent CPA firm tested LSPedia's controls over twelve months and issued an unqualified opinion.
  • Smoother vendor reviews: Security, procurement and audit teams get the documentation they routinely request for supplier qualification.
  • The full report under NDA: Customers and qualified prospects can request it through their LSPedia account team; LSPedia's Security team shares it through a secure channel.
  • A direct line to Security: Security and quality questionnaires go straight to LSPedia's security and quality leaders.

To request the SOC 2 Type II report, contact your LSPedia account manager or email trace@lspedia.com.

‍

About LSPedia - Empowering the Supply Chain

LSPedia builds serialization, traceability and compliance software for everyone who touches a prescription drug on its way to the patient. Its OneScan platform was built for DSCSA and resolves data exceptions instead of only flagging them. OneScan serves pharmaceutical manufacturers, wholesale distributors and 3PLs, health systems and pharmacies. LSPedia holds ISO 9001:2015 and ISO/IEC 27001:2022 certifications, is a GS1 US Elite Solutions Partner and has a current SOC 2 Type II report.

Traceability protects your business and fosters improved decision making. Contact LSPedia at (855) ONE-SCAN (663-7226), email marketing@lspedia.com or visit www.lspedia.com.

Media contact: marketing@lspedia.com

‍